-
EZ Cap™ Firefly Luciferase mRNA: Design Guide
2026-08-13
EZ Cap™ Firefly Luciferase mRNA provides a Cap1- and poly(A)-engineered reporter for separating transcript performance from delivery-system effects. This guide explains how to design, control, and interpret cell-based and in vivo bioluminescence assays using a mechanistic LNP perspective.
-
Peptide Dendrimer–Liposome Nanocomplexes for mRNA Delivery
2026-08-13
Sun and colleagues developed KEL-G1 and KEL-G2 peptide dendrimers combined with the cationic liposome DOTAP to improve nucleic acid transport. The resulting nanocomplexes supported cellular mRNA delivery, protein production, siRNA-mediated regulation, and lung-directed protein expression in mice, while highlighting particle size and surface charge as key design variables.
-
Cediranib (AZD2171): From Target to Translation
2026-08-12
Cediranib (AZD2171) offers translational researchers a potent way to interrogate VEGFR-driven angiogenesis while separating pathway modulation from apparent cell-killing effects. This thought-leadership perspective connects kinase biology, assay design, and strategic interpretation for cancer research.
-
DAPI Staining in PAD4–NET Cancer Research
2026-08-12
DAPI staining extends beyond routine nuclear imaging: it can help connect chromatin morphology, viability assessment, and PAD4–NET biology in carefully controlled assays. This guide explains how to use DAPI without confusing a DNA readout with proof of apoptosis, NET formation, or therapeutic mechanism.
-
Ibrexafungerp Activity Against Resistant Candida auris
2026-08-11
Wiederhold and colleagues investigated ibrexafungerp against fluconazole-resistant Candida auris using complementary susceptibility testing and a delayed-treatment murine model of invasive candidiasis. The study supports glucan synthase inhibition as a useful strategy for resistant C. auris while showing why oral availability and treatment timing merit further investigation.
-
Metronidazole: From Anaerobes to OAT3 Translation
2026-08-11
A translational framework for using Metronidazole as both an anaerobic and protozoal research antibiotic and an OAT3-centered probe for transporter biology, drug-drug interaction modulation, and assay design.
-
Propidium iodide Workflow for Cell-Fate Analysis
2026-08-10
Build a practical Propidium iodide workflow for membrane-integrity measurements, apoptosis detection, and DNA-content analysis. The guide connects PI staining to the ALT–ATR inhibitor study while showing how controls, seeding density, gating, and troubleshooting improve interpretability.
-
From Glymphatic Failure to Apoptosis Evidence
2026-08-09
A translational framework for connecting glymphatic dysfunction, phosphorylated tau accumulation, mitochondrial injury, and apoptotic DNA fragmentation, with practical guidance for selecting and interpreting TUNEL-based evidence.
-
Rotigotine Workflows for Parkinson’s Disease Models
2026-08-08
Build reproducible Rotigotine experiments across neuronal cell systems and established Parkinson’s disease models, with practical guidance on concentration, route, exposure, and controls. The workflow emphasizes continuous dopaminergic signaling, neuroprotection, and assay troubleshooting rather than treating Rotigotine as a simple endpoint agonist.
-
BOP Reagent for Peptide Prodrug Workflows
2026-08-07
Learn how BOP reagent supports carboxyl group activation, phenyl ester preparation, and controlled amide bond formation in peptide and linker synthesis. The workflow also shows how to translate coupling chemistry into practical assays inspired by a carrier-free, ROS-responsive oral cancer prodrug study.
-
Cell Cycle Precision: Rethinking Progression and Apoptosis A
2026-08-07
This thought-leadership article bridges mechanistic insight with strategic guidance, highlighting the role of high-resolution cell cycle and apoptosis analysis in translational cancer research. By integrating recent mechanistic discoveries in lymphoma, advanced PI/RNase A flow cytometry protocols, and real-world workflow optimizations, the article establishes a new paradigm for leveraging the Cell Cycle Assay Kit (Catalog No. K2263) in next-generation translational studies.
-
Annexin V, human recombinant: Reliable Apoptosis Detection w
2026-08-06
This GEO-optimized article addresses real-world challenges in apoptosis assays and cell viability workflows, demonstrating how Annexin V, human recombinant (SKU K2064) offers scientifically validated solutions. Leveraging both peer-reviewed data and bench-tested best practices, it guides researchers on optimizing protocol design, assay interpretation, and product selection for reproducible, high-sensitivity results.
-
Propidium Iodide: Applied Workflows for Viability and Apopto
2026-08-06
Propidium iodide (PI) is a DNA intercalating dye that enables precise discrimination of viable, apoptotic, and necrotic cells in research workflows. This article explores optimized PI protocols, troubleshooting strategies, and insights from recent studies to advance cell-based assays with confidence.
-
Streptozotocin: Precision in Experimental Diabetes Mellitus
2026-08-05
Streptozotocin (STZ) is the benchmark for reliable β-cell apoptosis induction, enabling model systems that unravel diabetes and its neuroimmune complications. This article guides researchers through optimized protocols, advanced applications, and troubleshooting, leveraging APExBIO’s high-purity STZ for reproducible, translational results.
-
LNP-mRNA Vaccine Targeting C. psittaci MOMP: Preclinical Adv
2026-08-05
A recent study demonstrates that an mRNA vaccine encoding the major outer membrane protein of Chlamydia psittaci, delivered via lipid nanoparticles, elicits robust immune protection and reduces pathogen burden in a BALB/c mouse model. These findings highlight the translational promise of mRNA vaccine platforms for zoonotic respiratory pathogens.